Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model.

Kate R SecombeImogen A BallJoseph ShirrenAnthony D WignallJohn FinnieDorothy KeefeFrancesca Avogadri-ConnorsElizabeth OlekDavid MartinSusan MoranJoanne M Bowen

Published in: Cancer chemotherapy and pharmacology (2018)

Both budesonide and colesevelam show potential as effective interventions against neratinib-induced diarrhea.

Keyphrases

high glucose
diabetic rats
drug induced
physical activity
irritable bowel syndrome
endothelial cells
positive breast cancer
human health
climate change